Videos

Roberto Pili, MD, discusses clinical challenges in translocation renal cell carcinoma. 
 

Dr. Pili on the Challenges of Translocation RCC

Bert O’Neil, MD, the Joseph W. and Jackie J. Cusick Professor of Oncology, professor of medicine, and director of the Phase I and Gastrointestinal Oncology Programs at Indiana University, discusses the importance of differentiating between neuroendocrine tumors (NETs).

Dr. O'Neil on Neuroendocrine Tumors

Articles

Paul R. Helft, MD, discusses the incidence of gastrointestinal neuroendocrine tumors and available and emerging treatment methods.

Expert Shares Insight on Navigating Neuroendocrine Tumor Treatment

Paul R. Helft, MD, professor of medicine, Indiana University School of Medicine, Indiana University Health Melvin and Bren Simon Cancer Center, discusses pancreatic and carcinoid neuroendocrine tumors.
 

Dr. Helft Discusses Pancreatic and Carcinoid NETs

With the growing body of evidence supporting positive outcomes with the use of precision medicine–based approaches, academic cancer centers are increasingly incorporating genomic technology into standard clinical care. 

Indiana University Researchers Find Precision Medicine Improves Outcomes

The program brings both high-school and undergraduate students from underrepresented populations to the IU School of Medicine's Indianapolis campus. It offers students positive and meaningful firsthand exposure to biomedical and behavioral science careers that might not otherwise present themselves.

Indiana University Melvin and Bren Simon Cancer Center

Latest from Indiana University Melvin and Bren Simon Cancer Center

New content coming soon, please check back later.